Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Oct 1;14(5):889-891.
doi: 10.21037/hbsn-2025-414. Epub 2025 Sep 25.

The challenge of sustaining therapeutic response in MASLD: insights from noninvasive liver assessment

Nobuharu Tamaki  1 , Masayuki Kurosaki  1
Affiliations
Editorial

The challenge of sustaining therapeutic response in MASLD: insights from noninvasive liver assessment

Nobuharu Tamaki et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Metabolic dysfunction-associated steatotic liver disease (MASLD); liver stiffness measurement; magnetic resonance imaging-proton density fat fraction (MRI-PDFF).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2025-414/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Mak LY, Liu K, Chirapongsathorn S, et al. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nat Rev Gastroenterol Hepatol 2024;21:834-51. 10.1038/s41575-024-00967-4 - DOI - PubMed
    1. Enomoto H, Akuta N, Hikita H, et al. Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021. Hepatol Res 2024;54:763-72. 10.1111/hepr.14047 - DOI - PubMed
    1. European Association for the Study of the Liver (EASL) European Association for the Study of Diabetes (EASD) ; European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 2024;81:492-542. 10.1016/j.jhep.2024.04.031 - DOI - PubMed
    1. Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol 2021;56:951-63. 10.1007/s00535-021-01796-x - DOI - PMC - PubMed
    1. Malespin MH, Barritt AS, 4th, Watkins SE, et al. Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort. Clin Gastroenterol Hepatol 2022;20:2393-2395.e4. 10.1016/j.cgh.2021.01.023 - DOI - PubMed